The case for market-driven drug affordability By John Murphy III Key Points Generic and biosimilar drugs are the main source of prescription drug savings, generating $467 billion in 2024 alone, with Medicare and Medicaid accounting fo... Read more President launches TrumpRx platform aimed at lowering prescription drug prices By HPN Staff Key Points President Trump introduced an online portal offering pre-negotiated, most-favored-nation pricing on 43 brand-name prescription drugs, with consumers accessing disco... Read more The drivers of rising costs: The price of hospitals, specialty services, and prescription drugs By Stephen Hemsley Key Points Hospital prices have grown nearly three times faster than inflation over the past 25 years and now account for more than 30% of total U.S. health care spendin... Read more Johnson & Johnson joins government push to lower drug prices, expand U.S. production By HPN Staff Johnson & Johnson reached a voluntary agreement with the U.S. government to lower certain prescription drug prices for patients and participate in a federal direct-to-consume... Read more Judge signs off on $7 billion Purdue Settlement after years of legal fights By HPN staff Key Points The approved $7 billion Purdue Pharma settlement represents one of the largest efforts to hold a pharmaceutical manufacturer financially accountable for its role in... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 The case for market-driven drug affordability 2 Wisconsin joins 48 other states to improve postpartum health care coverage 3 U.S. completes exit from global health organization 4 A move is underway to expand doctor supply by cutting licensing barriers DONATE
President launches TrumpRx platform aimed at lowering prescription drug prices By HPN Staff Key Points President Trump introduced an online portal offering pre-negotiated, most-favored-nation pricing on 43 brand-name prescription drugs, with consumers accessing disco... Read more The drivers of rising costs: The price of hospitals, specialty services, and prescription drugs By Stephen Hemsley Key Points Hospital prices have grown nearly three times faster than inflation over the past 25 years and now account for more than 30% of total U.S. health care spendin... Read more Johnson & Johnson joins government push to lower drug prices, expand U.S. production By HPN Staff Johnson & Johnson reached a voluntary agreement with the U.S. government to lower certain prescription drug prices for patients and participate in a federal direct-to-consume... Read more Judge signs off on $7 billion Purdue Settlement after years of legal fights By HPN staff Key Points The approved $7 billion Purdue Pharma settlement represents one of the largest efforts to hold a pharmaceutical manufacturer financially accountable for its role in... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 The case for market-driven drug affordability 2 Wisconsin joins 48 other states to improve postpartum health care coverage 3 U.S. completes exit from global health organization 4 A move is underway to expand doctor supply by cutting licensing barriers DONATE
The drivers of rising costs: The price of hospitals, specialty services, and prescription drugs By Stephen Hemsley Key Points Hospital prices have grown nearly three times faster than inflation over the past 25 years and now account for more than 30% of total U.S. health care spendin... Read more Johnson & Johnson joins government push to lower drug prices, expand U.S. production By HPN Staff Johnson & Johnson reached a voluntary agreement with the U.S. government to lower certain prescription drug prices for patients and participate in a federal direct-to-consume... Read more Judge signs off on $7 billion Purdue Settlement after years of legal fights By HPN staff Key Points The approved $7 billion Purdue Pharma settlement represents one of the largest efforts to hold a pharmaceutical manufacturer financially accountable for its role in... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma MOST VIEWED 1 The case for market-driven drug affordability 2 Wisconsin joins 48 other states to improve postpartum health care coverage 3 U.S. completes exit from global health organization 4 A move is underway to expand doctor supply by cutting licensing barriers DONATE
Johnson & Johnson joins government push to lower drug prices, expand U.S. production By HPN Staff Johnson & Johnson reached a voluntary agreement with the U.S. government to lower certain prescription drug prices for patients and participate in a federal direct-to-consume... Read more Judge signs off on $7 billion Purdue Settlement after years of legal fights By HPN staff Key Points The approved $7 billion Purdue Pharma settlement represents one of the largest efforts to hold a pharmaceutical manufacturer financially accountable for its role in... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Judge signs off on $7 billion Purdue Settlement after years of legal fights By HPN staff Key Points The approved $7 billion Purdue Pharma settlement represents one of the largest efforts to hold a pharmaceutical manufacturer financially accountable for its role in... Read more Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Spurring innovation in the biotech industry will save lives By John Crowley Key Points Crowley emphasized that maintaining U.S. leadership in biotechnology is vital to both public health and national security, especially amid China’s rapid rise in ... Read more Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Colorado drug affordability board faces suit over price fixing By HPN Staff Key Points For the second time, Amgen has sued Colorado’s Prescription Drug Affordability Review Board over its decision to cap the price of Enbrel, an autoimmune drug, at $60... Read more Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Ivermectin debate reignites as more states eye over-the-counter sales Key Points Florida and Ohio are considering bills to let pharmacies sell ivermectin without a prescription, joining at least 16 states exploring or enacting similar measures—five of which (Idaho,... Read more Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Colorado drug price cap raises concerns over access and innovation By HPN Staff Key Points Colorado became the first state to set a price cap on a specific prescription drug — limiting the cost of Enbrel, a rheumatoid arthritis treatment, to $600 per 50-m... Read more Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
Researchers sound alarm on spike in drug-resistant ‘nightmare bacteria’ By HPN Staff Key Points Infections from NDM-producing carbapenem-resistant Enterobacterales jumped by over 460 % in recent years — a startling increase in strains resistant to almost all ... Read more 1 2 Subscribe to Pharma
